MedTrace Logo

Yoga as a Therapy for Traumatic Experiences

NCT00269490 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2008-01-28

No results posted yet for this study

Summary

The purpose of the proposed research is to conduct a feasibility study of yoga as an adjunctive therapy for the treatment of posttraumatic stress disorder (PTSD) in 15 military personnel at the Walter Reed Army Medical Center (WRAMC) in Washington, DC. Participants will complete 10 weeks of yoga training, in addition to the continuing their usual and customary care for PTSD at WRAMC. The style of yoga chosen for this study, Yoga Nidra, uses deep relaxation, deep breathing and meditation to systematically reduce physical, emotional, mental, and even subconscious tension. After a diagnostic mental health assessment at baseline, participants will attend a total of 18 classes taught over a 10-week period and will practice daily at home using a compact disk provided by the instructor. Baseline measures will include the Patient Health Questionnaire, PD-HAT Trauma Questions, PTSD Symptom Scale - Interview, Fear of Loss of Vigilance Scale, and expectation of efficacy. The primary outcome measure will be the PTSD Checklist. Changes in health status, locus of control, and pain will be assessed over the course of the study. An additional goal of this study is to gather preliminary data on the anticipated effect size and feasibility of conducting a larger clinical study of the adjunctive use of yoga for the treatment of PTSD symptoms in enlisted military personnel.

Conditions

  • Post-Traumatic Stress Disorder

Interventions

BEHAVIORAL

Yoga Nidra

Sponsors & Collaborators

  • Walter Reed Army Medical Center

    collaborator FED

  • Samueli Institute for Information Biology

    lead OTHER

Principal Investigators

  • COL Charles C Engel, MD, MPA · Walter Reed Army Medical Center

  • Christine Goertz Choate, DC, PhD · Samueli Institute for Information Biology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2006-10-31
Completion
2007-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00269490 on ClinicalTrials.gov